Urinary Tract Infections
📧 Sign up to get email alerts when something new happens for Urinary Tract Infections.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-08-21FDA Approved: MEROPENEM — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Meropenem submitted by BluePoint Laboratories (ANDA205883), confirming approval of a supplementa…
-
FDA approval · 2024-09-27FDA Approved: CEPHALEXIN — Original Application (Ascend Laboratories, LLC)
FDA approved an original application for Cepalexin (cephalexin) from Ascend Laboratories, LLC, establishing a generic cephalexin product.
-
FDA approval · 2024-09-27FDA Approved: CEPHALEXIN — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Cephalexin from Aurobindo Pharma Limited.
-
FDA approval · 2024-03-14FDA Approved: DOXYCYCLINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for doxycycline, a generic antibiotic, expanding the availability of doxycycline pr…
-
FDA approval · 2023-10-31FDA Approved: AMPICILLIN — Original Application (Aurobindo Pharma Limited)
FDA approved an original application for Ampicillin from Aurobindo Pharma Limited, granting marketing authorization for a generic ampicillin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-10-12FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Eugia US LLC)
FDA approved the original abbreviated new drug application for piperacillin and tazobactam, a combination antibiotic manufactured by Eugia U…
-
FDA approval · 2023-09-13FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis Inc.)
FDA approved a generic Amoxicillin and clavulanate potassium product under Original Application by Devatis Inc.
-
FDA approval · 2019-12-19FDA Approved: CEFUROXIME AXETIL — Supplemental Application (Golden State Medical Supply, Inc.)
FDA approved a supplemental application for cefuroxime axetil from Golden State Medical Supply, Inc., recognizing an update to this generic …
-
FDA approval · 2019-08-16FDA Approved: MEROPENEM — Original Application (WG Critical Care, LLC)
FDA approved WG Critical Care, LLC's original ANDA for Meropenem, providing a generic version of the carbapenem antibiotic.
-
FDA approval · 2018-08-10FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Shandong Anxin Pharmaceutical Co., Ltd.)
FDA approved the original application for a generic Piperacillin and Tazobactam combination from Shandong Anxin Pharmaceutical Co., Ltd., ex…
-
FDA approval · 2016-10-18FDA Approved: DOXYCYCLINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves a supplemental application for doxycycline from Lupin Pharmaceuticals, Inc. to modify/expand an existing generic product approv…
-
FDA approval · 2014-09-26FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium from Teva Pharmaceuticals USA, Inc. The supplement rel…
-
FDA approval · 2012-01-20FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of amoxicillin and clavulanate potassium from Aurobindo Pharma Limited under an Original Application (ANDA 09…
-
FDA approval · 2011-05-04FDA Approved: CEPHALEXIN — Supplemental Application (AvKARE)
FDA approved a supplemental application for Cephalexin from AvKARE under ANDA 062713, authorizing continued manufacture and marketing of a C…
-
FDA approval · 2010-02-16FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s generic product Sulfamethoxazole and Trimethoprim as an Original Application (ANDA).